Código QR (código de barras bidimensional)

Multi-target antidiabetic therapy with voglibose, ubiquinone, and tempol: synergistic effects on liver and skeletal muscle in experimental type 2 diabetes

Abstract Background Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disorder marked by insulin resistance and chronic hyperglycemia. Although voglibose, an alpha-glucosidase inhibitor, is used in T2DM management, its efficacy is limited, particularly when used alone. This study aimed to i...

Fuld beskrivelse

Na minha lista:
Principais autores: Öznur Tufan Akarslan, Dudu Erkoç Kaya, Muhammed Bahaeddin Dörtbudak, Büşra Kilinç, İbrahim Büyüktaşkapulu, Fatma Göktürk, Muhammed Demircioğlu, Ayşe Er, Burak Dik
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2025-12-01
Serier:BMC Pharmacology and Toxicology
Fag:
Voglibose
Ubiquinone
Tempol
Insulin resistance
Online adgang:https://doi.org/10.1186/s40360-025-01071-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker